Difference between revisions of "Exendin 4"
m |
m |
||
| Line 28: | Line 28: | ||
| Substrate sequence | | Substrate sequence | ||
| TSDLS''K''QMEEE | | TSDLS''K''QMEEE | ||
| − | + | FIEWL''K''NGGPS | |
|- | |- | ||
| Structure | | Structure | ||
Revision as of 11:55, 12 September 2008
| Template:Infobox header| Exendin 4 | |
|---|---|
| Substrate peptide name | Exendin 4 |
| Synonyms | Exenatide |
| Determination type | In vitro |
| Source | Heloderma suspectum |
| Subcellular localization | Excreted |
| Swissprot ID | P26349 |
| Reactive glutamines | - |
| Reactive lysines | K12, K27 |
| Substrate sequence | TSDLSKQMEEE
FIEWLKNGGPS |
| Structure | 1JRJ |
| Surface accessibility | |
| Disorder prediction | IUPred |
| Reference | PMID:18761350 |
| Notes | It is a GIP-1 incretin mimetic having a role in the regulation of blood glucose level.
It is used in the medication of type II diabetes as Byetta (Amylin, Lilly). |
| Template:Infobox header | |
